Search Results - "XIAOJIANG CUI"

Refine Results
  1. 1

    COVID-19 in cancer patients: risk, clinical features, and management by Liu, Cuiwei, Zhao, Yanxia, Okwan-Duodu, Derick, Basho, Reva, Cui, Xiaojiang

    Published in Cancer biology & medicine (15-08-2020)
    “…A novel coronavirus known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread across the world, prompting the World Health Organization…”
    Get full text
    Journal Article
  2. 2

    Antibody-Drug Conjugates in Breast Cancer: Current Status and Future Directions by Mark, Cynthia, Lee, Jin Sun, Cui, Xiaojiang, Yuan, Yuan

    “…Antibody drug conjugates (ADCs) are novel medications that combine monoclonal antibodies with cytotoxic payloads, enabling the selective delivery of potent…”
    Get full text
    Journal Article
  3. 3

    A Collagen-Remodeling Gene Signature Regulated by TGF-β Signaling Is Associated with Metastasis and Poor Survival in Serous Ovarian Cancer by CHEON, Dong-Joo, YUNGUANG TONG, KARLAN, Beth Y, ORSULIC, Sandra, SIM, Myung-Shin, DERING, Judy, BEREL, Dror, XIAOJIANG CUI, LESTER, Jenny, BEACH, Jessica A, TIGHIOUART, Mourad, WALTS, Ann E

    Published in Clinical cancer research (01-02-2014)
    “…To elucidate molecular pathways contributing to metastatic cancer progression and poor clinical outcome in serous ovarian cancer. Poor survival signatures from…”
    Get full text
    Journal Article
  4. 4

    CDK4/6 Inhibitor Resistance in Hormone Receptor-Positive Metastatic Breast Cancer: Translational Research, Clinical Trials, and Future Directions by Lee, Jin Sun, Hackbart, Hannah, Cui, Xiaojiang, Yuan, Yuan

    “…The emergence of CDK4/6 inhibitors, such as palbociclib, ribociclib, and abemaciclib, has revolutionized the treatment landscape for hormone receptor-positive…”
    Get full text
    Journal Article
  5. 5

    Evaluation of MCF10A as a Reliable Model for Normal Human Mammary Epithelial Cells by Qu, Ying, Han, Bingchen, Yu, Yi, Yao, Weiwu, Bose, Shikha, Karlan, Beth Y, Giuliano, Armando E, Cui, Xiaojiang

    Published in PloS one (06-07-2015)
    “…Breast cancer is the most common cancer in women and a leading cause of cancer-related deaths for women worldwide. Various cell models have been developed to…”
    Get full text
    Journal Article
  6. 6

    Effects of hormones and hormone therapy on breast tissue in transgender patients: a concise review by Patel, Harsh, Arruarana, Victor, Yao, Lucille, Cui, Xiaojiang, Ray, Edward

    Published in Endocrine (01-04-2020)
    “…Purpose Hormone replacement therapy (HRT) has become a mainstay medical treatment option for management of gender dysphoria in transgender patients of both…”
    Get full text
    Journal Article
  7. 7

    FOXC1-induced non-canonical WNT5A-MMP7 signaling regulates invasiveness in triple-negative breast cancer by Han, Bingchen, Zhou, Bo, Qu, Ying, Gao, Bowen, Xu, Yali, Chung, Stacey, Tanaka, Hisashi, Yang, Wei, Giuliano, Armando E., Cui, Xiaojiang

    Published in Oncogene (01-03-2018)
    “…Triple-negative breast cancer (TNBC) has high rates of local recurrence and distant metastasis, partially due to its high invasiveness. The Forkhead box C1…”
    Get full text
    Journal Article
  8. 8

    Current status of research and treatment for non-small cell lung cancer in never-smoking females by Saito, Shin, Espinoza-Mercado, Fernando, Liu, Hui, Sata, Naohiro, Cui, Xiaojiang, Soukiasian, Harmik J.

    Published in Cancer biology & therapy (03-06-2017)
    “…Lung cancer is the leading cause of cancer-related deaths worldwide with over 1 million deaths each year. The overall prognosis of lung cancer patients remains…”
    Get full text
    Journal Article
  9. 9

    Identification of triptonide as a therapeutic agent for triple negative breast cancer treatment by Gao, Bowen, Chen, Jiongyu, Han, Bingchen, Zhang, Xinfeng, Hao, Jijun, Giuliano, Armando E., Cui, Yukun, Cui, Xiaojiang

    Published in Scientific reports (28-01-2021)
    “…Triple-negative breast cancer (TNBC) is associated with a high rate of early recurrence and distant metastasis, frequent development of therapeutic resistance,…”
    Get full text
    Journal Article
  10. 10

    Redox Regulation in Cancer Stem Cells by Xu, Xinglian, Cui, Xiaojiang, Cheng, Ninghui, Li, Chunbao, Ding, Shijie, Zhou, Guanghong

    Published in Oxidative medicine and cellular longevity (01-01-2015)
    “…Reactive oxygen species (ROS) and ROS-dependent (redox regulation) signaling pathways and transcriptional activities are thought to be critical in stem cell…”
    Get full text
    Journal Article
  11. 11

    Hypoxia‐stimulated ATM activation regulates autophagy‐associated exosome release from cancer‐associated fibroblasts to promote cancer cell invasion by Xi, Lei, Peng, Meixi, Liu, Shuiqing, Liu, Yongcan, Wan, Xueying, Hou, Yixuan, Qin, Yilu, Yang, Liping, Chen, Shanchun, Zeng, Huan, Teng, Yong, Cui, Xiaojiang, Liu, Manran

    Published in Journal of extracellular vesicles (01-09-2021)
    “…Cancer‐associated fibroblasts (CAFs) as a predominant cell component in the tumour microenvironment (TME) play an essential role in tumour progression. Our…”
    Get full text
    Journal Article
  12. 12

    A prognostic model of triple-negative breast cancer based on miR-27b-3p and node status by Shen, Songjie, Sun, Qiang, Liang, Zhiyong, Cui, Xiaojiang, Ren, Xinyu, Chen, Huan, Zhang, Xiao, Zhou, Yidong

    Published in PloS one (19-06-2014)
    “…Triple-negative breast cancer (TNBC) is an aggressive but heterogeneous subtype of breast cancer. This study aimed to identify and validate a prognostic…”
    Get full text
    Journal Article
  13. 13

    A Novel Long Non‐Coding RNA lnc030 Maintains Breast Cancer Stem Cell Stemness by Stabilizing SQLE mRNA and Increasing Cholesterol Synthesis by Qin, Yilu, Hou, Yixuan, Liu, Shuiqing, Zhu, Pengpeng, Wan, Xueying, Zhao, Maojia, Peng, Meixi, Zeng, Huan, Li, Qiao, Jin, Ting, Cui, Xiaojiang, Liu, Manran

    Published in Advanced science (01-01-2021)
    “…Cancer stem cells (CSCs) are considered the roots of cancer metastasis and recurrence (CSCs), due in part to their self‐renewal and therapy resistance…”
    Get full text
    Journal Article
  14. 14

    FOXC1 Is a Potential Prognostic Biomarker with Functional Significance in Basal-like Breast Cancer by RAY, Partha S, JINHUA WANG, WALTER, Michael A, MARTENS, John W, RICHARDSON, Andrea L, GIULIANO, Armando E, XIAOJIANG CUI, YING QU, SIM, Myung-Shin, SHAMONKI, Jaime, BAGARIA, Sanjay P, XING YE, BINGYA LIU, ELASHOFF, David, HOON, Dave S

    Published in Cancer research (Chicago, Ill.) (15-05-2010)
    “…Gene expression signatures for a basal-like breast cancer (BLBC) subtype have been associated with poor clinical outcomes, but a molecular basis for this…”
    Get full text
    Journal Article
  15. 15

    Stratification of Prognosis of Triple-Negative Breast Cancer Patients Using Combinatorial Biomarkers by Yue, Yong, Astvatsaturyan, Kristine, Cui, Xiaojiang, Zhang, Xiao, Fraass, Benedick, Bose, Shikha

    Published in PloS one (01-03-2016)
    “…Triple-negative breast cancer (TNBC) is highly diverse group of cancers, and generally considered an aggressive disease associated with poor survival…”
    Get full text
    Journal Article
  16. 16
  17. 17
  18. 18

    Personalizing breast cancer staging by the inclusion of ER, PR, and HER2 by Bagaria, Sanjay P, Ray, Partha S, Sim, Myung-Shin, Ye, Xing, Shamonki, Jaime M, Cui, Xiaojiang, Giuliano, Armando E

    Published in JAMA surgery (01-02-2014)
    “…Nonanatomic factors, such as histologic grade and biomarkers, can guide breast cancer management but are not included in the current TNM staging system. To use…”
    Get more information
    Journal Article
  19. 19
  20. 20

    Single protein encapsulated SN38 for tumor-targeting treatment by Yu, Changjun, Huang, Faqing, Wang, Kinsley, Liu, Mengmeng, Chow, Warren A, Ling, Xiang, Li, Fengzhi, Causey, Jason L, Huang, Xiuzhen, Cook-Wiens, Galen, Cui, Xiaojiang

    Published in Journal of translational medicine (10-12-2023)
    “…The alkaloid camptothecin analog SN38 is a potent antineoplastic agent, but cannot be used directly for clinical application due to its poor water solubility…”
    Get full text
    Journal Article